Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C - Wikidata - awgldk - TriplyDB

Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C

Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C

http://www.wikidata.org/entity/Q35187157

about

Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation HIV-1 drug resistance and resistance testing.Implementation of a point mutation assay for HIV drug resistance testing in Kenya

P2860

Q28552499-431C83A1-4D3A-4616-AAC9-316E32144C24 Q30245693-F8F817CE-AD48-4AD0-8BB3-6B11471D4523 Q57131360-E213B710-21FA-4E3B-A7DB-1BDBA504AB3A

P2860

Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C

http://www.wikidata.org/entity/Q35187157

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Optimization of the oligonucle ...... iciency Virus type-1 subtype C

@ast

Optimization of the oligonucle ...... iciency Virus type-1 subtype C

@en

type

label

Optimization of the oligonucle ...... iciency Virus type-1 subtype C

@ast

Optimization of the oligonucle ...... iciency Virus type-1 subtype C

@en

prefLabel

Optimization of the oligonucle ...... iciency Virus type-1 subtype C

@ast

Optimization of the oligonucle ...... iciency Virus type-1 subtype C

@en

P1433

Q35187157-59B7179A-FDE2-4B3C-A299-368E11261D09

P1476

Q35187157-12515C9B-D83B-4A11-A403-87C59049E3B9

P2093

Q35187157-13C14CD7-3D37-496C-856A-CFECB8D16E83

Q35187157-1B25FF01-BFD3-45A2-87F9-6B519C43ECFD

Q35187157-39817BA0-B1FF-4B5B-968E-5FEA98AFB8F5

Q35187157-68E48BA6-2AD5-4E47-BF3F-DF9B61311A5A

Q35187157-B9142B26-A526-4F3B-AC4F-FEF7DE1B133F

Q35187157-BF38678A-185F-4ECD-8909-F1B209D6C49F

Q35187157-FDAEBCAC-2048-49AA-A099-0C606050BE62

P2860

Q35187157-1B7E8096-6B00-4D60-BDB9-D75FB0E06C9A

Q35187157-223DFFB3-A180-4D1E-8E5C-E3686DC03477

Q35187157-24FA2884-70BD-468B-99CC-6E222914FAFC

Q35187157-37DE7902-20A8-4608-93A2-84D454C0F95F

Q35187157-43DDFE53-E05E-41C3-85AB-549B9641B67C

Q35187157-4F450A9B-34A7-4356-935A-C1EB6B50693D

Q35187157-516B0946-F5A6-4361-B38B-36CE738D320B

Q35187157-6C08B08C-0B10-44DB-8609-B9C123D45B50

Q35187157-725C5246-85FF-4183-8357-B90828860E0B

Q35187157-81551851-C976-4D58-9B79-B4190DB89E3E

P304

Q35187157-0A4FCA49-9C0E-4E71-9436-8444C98783EE

P31

Q35187157-78781F90-8ECF-4FF0-8DEB-82EDF601F8B3

P356

Q35187157-C3510678-7550-4E7F-975E-B5EDED9A58F1

P478

Q35187157-7FDE206E-756E-4F93-B162-DF2C49B52D79

P577

Q35187157-34681336-0AB4-40C9-9630-14B6C9701C8F

P5875

Q35187157-E5A5726C-EF69-4409-A4D6-6A1709AC282C

P698

Q35187157-3110E05D-4BB3-4946-A9B4-390F83642EB5

P921

Q35187157-CE408C76-8929-463D-95B0-55585489FECB

P932

Q35187157-3560B089-1044-4F6A-BE94-6906B1B584F9

P356

J.JVIROMET.2014.09.005

P1433

Journal of Virological Methods

P1476

Optimization of the oligonucle ...... iciency Virus type-1 subtype C

@en

P2093

I A Beck

http://www.w3.org/2001/XMLSchema#string

J Mutsvangwa

http://www.w3.org/2001/XMLSchema#string

L Gwanzura

http://www.w3.org/2001/XMLSchema#string

L M Frenkel

http://www.w3.org/2001/XMLSchema#string

L Stranix-Chibanda

http://www.w3.org/2001/XMLSchema#string

M T Manhanzva

http://www.w3.org/2001/XMLSchema#string

T Chipato

http://www.w3.org/2001/XMLSchema#string

P2860

Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: a cross-sectional analytic study.

Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.

Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.

Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.

Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.

Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.

Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma.

Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.

Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.

P304

36-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVIROMET.2014.09.005

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265860133

http://www.w3.org/2001/XMLSchema#string

P698

25239368

http://www.w3.org/2001/XMLSchema#string

P921

P932

4363305

http://www.w3.org/2001/XMLSchema#string